Foreign Filer Report • Apr 3, 2025
Foreign Filer Report
Open in ViewerOpens in native device viewer
Form 13G - OPKO Health Inc. holdings of Entera Bio Ltd.���� ������ ��� ����� - ������ ����� ����� Entera Bio Ltd. false
| ����� ���', ���� | 2 380 |
| OPKO HEALTH, INC | |
| Corporation no: 2279206 | 13156 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 03/04/2025 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2025-02-024437 | Time of broadcast: 08:34 08:34 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onForm 13G - OPKO Health Inc. holdings of Entera Bio Ltd. ���� ������ ��� ����� - ������ ����� ����� Entera Bio Ltd.
20250403Form13G_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ GSM | Date of revision of form structure: 06/08/2024 |
| Address: Ashlegan 16 , Kiryat Gat 8211804 Israel , Tel: 08-9300051 , Fax: 08-9543101 | |
| E-mail address: [email protected] Company site: Www.Opko.Com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Faibish Gabriel Position of Signatory in the reporting corporation: General Counsel Name of Employer Company: | |
| Address: Ashlegan 16 , Kiryat Gat 8211804 Telephone: 08-9300051 Facsimile: 08-9543101 E-mail: [email protected] 1 | |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.